| scholarly article | Q13442814 |
| P50 | author | Kassapa Ellepola | Q61159377 |
| Cristiane Yumi Koga-Ito | Q42877124 | ||
| P2093 | author name string | Chaminda J Seneviratne | |
| Guilherme R Teodoro | |||
| P2860 | cites work | Antiulcer and antimicrobial activity of Anogeissus latifolia | Q28194513 |
| Carcinogenicity of antioxidants BHA, caffeic acid, sesamol, 4-methoxyphenol and catechol at low doses, either alone or in combination, and modulation of their effects in a rat medium-term multi-organ carcinogenesis model | Q28262455 | ||
| Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis | Q28377349 | ||
| Inhibitors of the glyoxylate cycle enzyme ICL1 in Candida albicans for potential use as antifungal agents | Q28538283 | ||
| Synergistic antifungal effect of glabridin and fluconazole | Q28541182 | ||
| Nosocomial candidemia; risk factors and prognosis revisited; 11 years experience from a Norwegian secondary hospital | Q28541447 | ||
| Natural products as sources of new drugs over the 30 years from 1981 to 2010 | Q29616640 | ||
| Plant products as antimicrobial agents | Q33749123 | ||
| Salivary α-amylase, serum albumin, and myoglobin protect against DNA-damaging activities of ingested dietary agents in vitro | Q33893423 | ||
| A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence | Q33982558 | ||
| Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins | Q33993336 | ||
| Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans | Q34088663 | ||
| Bisbibenzyls, a new type of antifungal agent, inhibit morphogenesis switch and biofilm formation through upregulation of DPP3 in Candida albicans | Q34103520 | ||
| Cranberry proanthocyanidins inhibit the adherence properties of Candida albicans and cytokine secretion by oral epithelial cells. | Q34128550 | ||
| Oral candidosis--clinical challenges of a biofilm disease | Q34202383 | ||
| Antifungal agents: mechanisms of action | Q34208354 | ||
| Correlates of acute renal failure in patients receiving parenteral amphotericin B. | Q34384041 | ||
| Reversal of efflux mediated antifungal resistance underlies synergistic activity of two monoterpenes with fluconazole. | Q34461875 | ||
| Invasive Candidiasis | Q34497221 | ||
| Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009 | Q34529179 | ||
| Phenolic compounds and antimicrobial activity of olive (Olea europaea L. Cv. Cobrançosa) leaves. | Q34583048 | ||
| Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy | Q34721774 | ||
| An integrated model of the recognition of Candida albicans by the innate immune system. | Q34725594 | ||
| The emerging world of the fungal microbiome | Q34727901 | ||
| Phytochemical profiles, antioxidant and antimicrobial activities of three Potentilla species | Q35046845 | ||
| Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance. | Q35129428 | ||
| In pursuit of the ideal antifungal agent for Candida infections: high-throughput screening of small molecules | Q35192676 | ||
| In vitro models for studying toxicity of antifungal agents | Q35447528 | ||
| Global trends in candidemia: review of reports from 1995-2005. | Q36286490 | ||
| Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida. | Q52603576 | ||
| An antifungal mechanism of curcumin lies in membrane-targeted action within Candida albicans. | Q52654877 | ||
| Ocimum sanctum (L.) essential oil and its lead molecules induce apoptosis in Candida albicans. | Q52772324 | ||
| Propyl gallate increases in vitro antifungal imidazole activity against Candida albicans. | Q54021066 | ||
| Antimicrobial effects of Finnish plant extracts containing flavonoids and other phenolic compounds. | Q54297595 | ||
| Spectroscopic (FT-IR, FT-Raman, 1H, 13C NMR, UV/VIS), thermogravimetric and antimicrobial studies of Ca(II), Mn(II), Cu(II), Zn(II) and Cd(II) complexes of ferulic acid. | Q54298823 | ||
| Investigation of chemical compounds, antioxidant and antimicrobial properties of teucrium arduini L. (lamiaceae). | Q54312906 | ||
| Phenolic compounds and biological activity of Kitaibelia vitifolia. | Q54354019 | ||
| Phenolics: From Chemistry to Biology | Q57252999 | ||
| Phenolic acids content, antioxidant and antimicrobial activity ofLigusticum mutellinaL | Q61875743 | ||
| Degradation of some phenols and hydroxybenzoates by the imperfect ascomycetous yeasts Candida parapsilosis and Arxula adeninivorans: evidence for an operative gentisate pathway | Q67567978 | ||
| Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia | Q73760628 | ||
| Synergic anticandidal effect of epigallocatechin-O-gallate combined with amphotericin B in a murine model of disseminated candidiasis and its anticandidal mechanism | Q81163886 | ||
| The evaluation of the genotoxicity of two food preservatives: sodium benzoate and potassium benzoate | Q82734569 | ||
| Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms | Q82943372 | ||
| Polyphenolic compounds and in vitro antimicrobial and antioxidant activity of aqueous extracts from leaves of some Cirsium species | Q82980769 | ||
| Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans | Q83057273 | ||
| In vitro antifungal activities of longan (Dimocarpus longan Lour.) seed extract | Q83243999 | ||
| Inhibition of Candida albicans biofilm formation and yeast-hyphal transition by 4-hydroxycordoin | Q83480785 | ||
| [In vitro activity of gallic acid against Candida albicans biofilms] | Q84416446 | ||
| In vitro genotoxicity assessment of caffeic, cinnamic and ferulic acids | Q84459489 | ||
| At what cost echinocandin resistance? | Q84596484 | ||
| Fungicidal effect of isoquercitrin via inducing membrane disturbance | Q86102332 | ||
| Cytotoxic, antioxidant, antimicrobial properties and chemical composition of rose petals | Q87031426 | ||
| Utilising polyphenols for the clinical management of Candida albicans biofilms | Q87524876 | ||
| Self-assembled cardanol azo derivatives as antifungal agent with chitin-binding ability | Q87894732 | ||
| Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009) | Q42905530 | ||
| Synthesis, anti-fungal and 1,3-β-d-glucan synthase inhibitory activities of caffeic and quinic acid derivatives | Q42919156 | ||
| The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans | Q42948079 | ||
| In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates | Q42969053 | ||
| Antifungal activity of baicalein against Candida krusei does not involve apoptosis | Q42976442 | ||
| Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans | Q43028575 | ||
| Antimicrobial activity of phenolic acids against commensal, probiotic and pathogenic bacteria. | Q43069559 | ||
| The effects of tea polyphenols on Candida albicans: inhibition of biofilm formation and proteasome inactivation | Q43246060 | ||
| Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida | Q43260025 | ||
| Toxic dose of a simple phenolic antioxidant, protocatechuic acid, attenuates the glutathione level in ICR mouse liver and kidney | Q43803368 | ||
| Enhanced contact activity of fluconazole in association with antioxidants against fluconazole-resistant organisms | Q44088896 | ||
| Increase of activity of tioconazole against resistant microorganisms by the addition of butylated hydroxyanisole | Q44604619 | ||
| Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans | Q44701296 | ||
| Antimicrobial activity of fractions and compounds from Calophyllumbrasiliense (Clusiaceae/Guttiferae). | Q45148525 | ||
| Bioactive ellagitannins from Cunonia macrophylla, an endemic Cunoniaceae from New Caledonia | Q45225744 | ||
| Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland | Q45738655 | ||
| Antimicrobial activities of components of the glandular secretions of leaf cutting ants of the genus Atta. | Q45930778 | ||
| Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species. | Q45933630 | ||
| Antifungal activity of thymol against clinical isolates of fluconazole-sensitive and -resistant Candida albicans. | Q45968328 | ||
| Antioxidant and antimicrobial activities of the edible medicinal halophyte Tamarix gallica L. and related polyphenolic constituents. | Q45980945 | ||
| Antimicrobial activity of the crude extract, fractions and compounds from stem bark of Ficus ovata (Moraceae). | Q46007146 | ||
| Phytochemical and antifungal studies on Terminalia mollis and Terminalia brachystemma. | Q46009417 | ||
| Candida albicans cells lacking CaMCA1-encoded metacaspase show resistance to oxidative stress-induced death and change in energy metabolism | Q46218805 | ||
| In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant to fluconazole | Q46222713 | ||
| Effects of styrene and its metabolites on different lung compartments of the mouse--cell proliferation and histomorphology | Q46492695 | ||
| Antimicrobial activity of three baccharis species used in the traditional medicine of Northern Chile. | Q46607091 | ||
| Inhibitory activity of thymol against the formation and viability of Candida albicans hyphae | Q46943616 | ||
| Berry phenolics: antimicrobial properties and mechanisms of action against severe human pathogens. | Q50079372 | ||
| Subchronic toxicity study of gallic acid by oral administration in F344 rats | Q50113605 | ||
| Antibacterial activity and mode of action of ferulic and gallic acids against pathogenic bacteria. | Q50482997 | ||
| Antimicrobial activity and phenolic content of natural site and micropropagated Limonium avei (De Not.) Brullo & Erben plant extracts. | Q50999252 | ||
| Fungal biofilms and antimycotics | Q36352159 | ||
| Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies | Q36506378 | ||
| Candida albicans biofilm development, modeling a host-pathogen interaction. | Q36525072 | ||
| Frequency, intensity, species, and strains of oral Candida vary as a function of host age. | Q36538036 | ||
| In search of the holy grail of antifungal therapy | Q36672181 | ||
| Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact | Q37048679 | ||
| Fungicidal versus Fungistatic: what's in a word? | Q37123394 | ||
| Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species | Q37480190 | ||
| The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis | Q37489316 | ||
| Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation | Q37607324 | ||
| Cranberry-derived proanthocyanidins prevent formation of Candida albicans biofilms in artificial urine through biofilm- and adherence-specific mechanisms. | Q37608358 | ||
| Synergistic effect of the flavonoid catechin, quercetin, or epigallocatechin gallate with fluconazole induces apoptosis in Candida tropicalis resistant to fluconazole | Q37643678 | ||
| Antifungal drug resistance of oral fungi | Q37692277 | ||
| Candida biofilms and oral candidosis: treatment and prevention | Q37816546 | ||
| Management of invasive fungal infections: a role for polyenes | Q37822572 | ||
| The effect of biomaterials and antifungals on biofilm formation by Candida species: a review | Q38009721 | ||
| Techniques for analysis of plant phenolic compounds | Q38083485 | ||
| Early state research on antifungal natural products. | Q38194442 | ||
| Candida survival strategies | Q38441454 | ||
| An evaluation of the possible neurotoxicity of metabolites of phenylalanine | Q38626868 | ||
| Antifungal activity of extracts and isolated compounds from Buchenavia tomentosa on Candida albicans and non-albicans. | Q38997402 | ||
| Enhanced activity of antifungal drugs using natural phenolics against yeast strains of Candida and Cryptococcus. | Q38999537 | ||
| Activity of caffeic acid derivatives against Candida albicans biofilm. | Q39019743 | ||
| Antifungal activity of phenolic compounds identified in flowers from North Eastern Portugal against Candida species | Q39244568 | ||
| Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients. | Q39279261 | ||
| Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids | Q39578152 | ||
| Influence of Antioxidants on the Bioactivity of Amphotericin B | Q40617114 | ||
| Synergistic Action of Amphotericin B and Antioxidants Against Certain Opportunistic Yeast Pathogens | Q40618020 | ||
| In vitro activity of propyl gallate-azole drug combination against fluconazole- and itraconazole-resistant Candida albicans strains. | Q40713997 | ||
| Catabolism of benzene compounds by ascomycetous and basidiomycetous yeasts and yeastlike fungi. A literature review and an experimental approach | Q40789776 | ||
| Cinnamic Acid is partially involved in propolis immunomodulatory action on human monocytes | Q41428329 | ||
| Antimicrobial activity of Schinus lentiscifolius (Anacardiaceae). | Q42711180 | ||
| A comparative study of anti-Candida activity and phenolic contents of the calluses from Lythrum salicaria L. in different treatments. | Q42712501 | ||
| Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans | Q42733449 | ||
| Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle | Q42733780 | ||
| Combination of baicalein and Amphotericin B accelerates Candida albicans apoptosis | Q42745774 | ||
| The uraemic toxin phenylacetic acid inhibits osteoblastic proliferation and differentiation: an implication for the pathogenesis of low turnover bone in chronic renal failure | Q42826419 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1420 | |
| P577 | publication date | 2015-12-21 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | Potential Use of Phenolic Acids as Anti-Candida Agents: A Review | |
| P478 | volume | 6 |
| Q37344546 | A complex game of hide and seek: the search for new antifungals |
| Q40424288 | Antifungal Activity of Oleuropein against Candida albicans-The In Vitro Study. |
| Q40110374 | Antifungal mechanism of the combination of Cinnamomum verum and Pelargonium graveolens essential oils with fluconazole against pathogenic Candida strains |
| Q26752569 | Antioxidant Secondary Metabolites in Cereals: Potential Involvement in Resistance to Fusarium and Mycotoxin Accumulation |
| Q38700372 | Chemical Composition, Antibacterial and Antifungal Activities of Crude Dittrichia viscosa (L.) Greuter Leaf Extracts |
| Q64248503 | Chemical Composition, Antifungal, and Cytotoxicity Activities of (Sw.) Willd Leaves |
| Q55098668 | Dermatophyte Resistance to Antifungal Drugs: Mechanisms and Prospectus. |
| Q55036519 | Effects of Acetone Fraction From Buchenavia tomentosa Aqueous Extract and Gallic Acid on Candida albicans Biofilms and Virulence Factors. |
| Q90600387 | Effects of Terminalia catappa Linn. Extract on Candida albicans biofilms developed on denture acrylic resin discs |
| Q36278629 | Honokiol induces reactive oxygen species-mediated apoptosis in Candida albicans through mitochondrial dysfunction |
| Q41561738 | Honokiol induces superoxide production by targeting mitochondrial respiratory chain complex I in Candida albicans |
| Q38756469 | Hydroxycinnamic Acids and Their Derivatives: Cosmeceutical Significance, Challenges and Future Perspectives, a Review. |
| Q59128280 | Hydroxytyrosol (HT) Analogs Act as Potent Antifungals by Direct Disruption of the Fungal Cell Membrane |
| Q57154099 | Influence of Eugenia uniflora Extract on Adhesion to Human Buccal Epithelial Cells, Biofilm Formation, and Cell Surface Hydrophobicity of Candida spp. from the Oral Cavity of Kidney Transplant Recipients |
| Q64268336 | Metabolic Profiling of Candida auris, a Newly-Emerging Multi-Drug Resistant Candida Species, by GC-MS |
| Q47215016 | Multifunctional Shape-Memory Polymer Foams with Bio-inspired Antimicrobials |
| Q92479806 | Pharmacological effects of gallic acid in health and diseases: A mechanistic review |
| Q47603145 | Phenolic acids in cereal grain: Occurrence, biosynthesis, metabolism and role in living organisms |
| Q37742873 | Phytochemical Characterization of Terminalia catappa Linn. Extracts and Their antifungal Activities against Candida spp. |
| Q91640281 | Potential targets for the development of new antifungal drugs |
| Q92156106 | Utilizing Liposomal Quercetin and Gallic Acid in Localized Treatment of Vaginal Candida Infections |
Search more.